Insider Selling: Trupanion (NASDAQ:TRUP) CFO Sells $183,391.11 in Stock

Trupanion, Inc. (NASDAQ:TRUP) CFO Fawwad Qureshi sold 6,111 shares of the company’s stock in a transaction that occurred on Wednesday, August 26th. The stock was sold at an average price of $30.01, for a total transaction of $183,391.11. Following the completion of the transaction, the chief financial officer owned 4,230 shares of the company’s stock, valued at approximately $126,942.30. The trade was a 59.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Trupanion Price Performance

Shares of NASDAQ TRUP traded down $1.65 during midday trading on Wednesday, reaching $30.19. The stock had a trading volume of 678,107 shares, compared to its average volume of 439,698. The company has a market capitalization of $1.32 billion, a price-to-earnings ratio of 56.96, a price-to-earnings-growth ratio of 2.15 and a beta of 1.39. Trupanion, Inc. has a 12-month low of $21.16 and a 12-month high of $46.98. The stock has a 50-day moving average of $26.63 and a 200-day moving average of $26.02. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.77 and a current ratio of 1.77.

Trupanion (NASDAQ:TRUP) last released its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, beating analysts’ consensus estimates of $0.11 by $0.05. The company had revenue of $392.93 million for the quarter, compared to analysts’ expectations of $389.72 million. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. Trupanion’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.22 EPS. As a group, research analysts anticipate that Trupanion, Inc. will post 0.63 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of TRUP. Royal Bank of Canada increased its position in Trupanion by 60.6% in the first quarter. Royal Bank of Canada now owns 29,763 shares of the financial services provider’s stock worth $1,109,000 after purchasing an additional 11,233 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Trupanion by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,603 shares of the financial services provider’s stock valued at $731,000 after purchasing an additional 858 shares during the last quarter. Millennium Management LLC grew its stake in shares of Trupanion by 73.5% in the 1st quarter. Millennium Management LLC now owns 267,976 shares of the financial services provider’s stock worth $9,987,000 after buying an additional 113,490 shares in the last quarter. Invesco Ltd. grew its stake in shares of Trupanion by 35.1% in the 2nd quarter. Invesco Ltd. now owns 187,749 shares of the financial services provider’s stock worth $10,392,000 after buying an additional 48,781 shares in the last quarter. Finally, Gabelli Funds LLC bought a new stake in shares of Trupanion in the 2nd quarter worth about $249,000.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. Stifel Nicolaus boosted their price target on Trupanion from $28.00 to $29.00 and gave the stock a “hold” rating in a report on Thursday, August 20th. Atlantic Securities set a $42.00 target price on shares of Trupanion in a report on Wednesday, July 15th. Piper Sandler lowered shares of Trupanion from an “overweight” rating to a “neutral” rating and dropped their target price for the stock from $45.00 to $32.00 in a research report on Wednesday. Weiss Ratings upgraded shares of Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, August 12th. Finally, Zacks Research downgraded shares of Trupanion from a “strong-buy” rating to a “hold” rating in a report on Monday. One analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Trupanion has a consensus rating of “Hold” and an average price target of $39.20.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.